If you're so minded, you can read a new paper I've co-written (The Human Cost of Pharmaceutical Price Controls in Europe: A Case for Reform), here.

The paper argues, in brief, that on the conservative assumption that one per cent of patients heavily dependent on their medication are worried by well-founded reports of counterfeiting into not taking their medication as recommended by their doctors, 370,000 people throughout the European Union are at any particular moment at risk of death or serious decline in their quality of life.

Taking this figure and averaging it throughout the year, over 42 people
per hour can be seen to be at risk of death because of some of the problems raised by attempts to reduce the price of pharmaceutical products within the European Union.

Confining this to the populations most at risk as the main destinations
of parallel imports – Britain and Germany (140 million) – and further reducing the figure of those not taking their medication from one per cent to 0.1 per cent, the figure is 14,000 per year – or a potential death rate of 1.6 per hour.

Go cure your insomnia...